|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | 慢性肾脏病患者铁剂应用的争议:来自改善全球肾脏病预后组织(KDIGO)会议的结论显示文摘慢性肾脏病和终末期肾病患者常需补铁治疗。但近年来铁剂的使用逐年增加,带来了铁超载、氧化应激和超敏反应等新问题,并可能促进感染的发生,其使用的安全性受到关注。为此,改善全球肾脏病预后组织(KDIGO)召开专家组会议,全面评估铁剂使用的利和弊,并且提供合理使用方案以减轻急性反应及其他毒副作用。 | Iain C.Macdougall Andreas J.Bircher Kai-Uwe Eckardt Gregorio T.Obrador Carol A.Pollock Peter Stenvinkel Dorine W.Swinkels Christoph Wanner Gü nter Weiss Glenn M.Chertow 陈佩玲(翻译) 龚德华(审校) | 2016 | 肾脏病与透析肾移植杂志2016，，4： | 5 |
| 2 | Association of low fetuin-A (AHSG) concentrations in serum with cardiovascular mortality in patients on dialysis: a cross-sectional study显示文摘 | Markus Ketteler Philipp Bongartz Ralf Westenfeld Joachim Ernst Wildberger Andreas Horst Mahnken Roland B?hm Thomas Metzger Christoph Wanner Willi Jahnen-Dechent Jürgen Floege | 2003 | The Lancet2003，，9360： | 2 |
| 3 | The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial显示文摘 | Colin Baigent Martin J Landray Christina Reith Jonathan Emberson David C Wheeler Charles Tomson Christoph Wanner Vera Krane Alan Cass Jonathan Craig Bruce Neal Lixin Jiang Lai Seong Hooi Adeera Levin Lawrence Agodoa Mike Gaziano Bertram Kasiske Robert Wal | 2011 | The Lancet2011，，9784： | 1 |
| 4 | Association of low fetuin-A (AHSG) concentrations in serum with cardiovascular mortality in patients on dialysis: a cross-sectional study显示文摘 | Markus Ketteler Philipp Bongartz Ralf Westenfeld Joachim Ernst Wildberger Andreas Horst Mahnken Roland B?hm Thomas Metzger Christoph Wanner Willi Jahnen-Dechent Jürgen Floege | 2003 | The Lancet2003，，9360： | 1 |
| 5 | North Atlantic Oscillation – Concepts And Studies显示文摘 | Heinz Wanner Stefan Br?nnimann Carlo Casty Dimitrios Gyalistras Jürg Luterbacher Christoph Schmutz David B. Stephenson Eleni Xoplaki | 2001 | Surveys in Geophysics2001，，4： | 1 |
| 6 | Lipoprotein‐associated phospholipase A2 and outcome in patients with type 2 diabetes on haemodialysis显示文摘 | Karl Winkler Michael M. Hoffmann Vera Krane Christiane Drechsler Christoph Wanner | 2011 | European Journal of Clinical Investigation2011，，7： | 1 |
| 7 | An international Delphi consensus statement on metabolic dysfunction-associated fatty liver disease and risk of chronic kidney disease显示文摘Background:With the rising global prevalence of fatty liver disease related to metabolic dysfunction,the association of this common liver condition with chronic kidney disease(CKD)has become increasingly evident.In 2020,the more inclusive term metabolic dysfunction-associated fatty liver disease(MAFLD)was proposed to replace the term non-alcoholic fatty liver disease(NAFLD).The observed association between MAFLD and CKD and our understanding that CKD can be a consequence of underlying metabolic dysfunction support the notion that individuals with MAFLD are at higher risk of having and developing CKD compared with those without MAFLD.However,to date,there is no appropriate guidance on CKD in individuals with MAFLD.Furthermore,there has been little attention paid to the link between MAFLD and CKD in the Nephrology community.Methods and Results:Using a Delphi-based approach,a multidisciplinary panel of 50 international experts from 26 countries reached a consensus on some of the open research questions regarding the link between MAFLD and CKD.Conclusions:This Delphi-based consensus statement provided guidance on the epidemiology,mechanisms,management and treatment of MAFLD and CKD,as well as the relationship between the severity of MAFLD and risk of CKD,which establish a framework for the early prevention and management of these two common and interconnected diseases. | Dan-Qin Sun Giovanni Targher Christopher D.Byrne David C.Wheeler Vincent Wai-Sun Wong Jian-Gao Fan Herbert Tilg Wei-Jie Yuan Christoph Wanner Xin Gao Michelle T.Long Mehmet Kanbay Mindie H.Nguyen Sankar D.Navaneethan Yusuf Yilmaz Yuli Huang Rino A.Gani Pierluigi Marzuillo Jérôme Boursier Huijie Zhang Chan-Young Jung Jin Chai Luca Valenti George Papatheodoridis Giovanni Musso Yu-Jun Wong Mohamed El-Kassas Nahum Méndez-Sánchez Silvia Sookoian Michael Pavlides Ajay Duseja Adriaan G.Holleboom Junping Shi Wah-Kheong Chan Yasser Fouad Junwei Yang Sombat Treeprasertsuk Helena Cortez-Pinto Masahide Hamaguchi Manuel Romero-Gomez Mamun Al Mahtab Ponsiano Ocama Atsushi Nakajima Chunsun Dai Mohammed Eslam Lai Wei Jacob George Ming-Hua Zheng | 2023 | Hepatobiliary Surgery and Nutrition2023，12，3： | 1 |
| 8 | Association of low fetuin-A (AHSG) concentrations in serum with cardiovascular mortality in patients on dialysis: a cross-sectional study显示文摘 | Markus Ketteler Philipp Bongartz Ralf Westenfeld Joachim Ernst Wildberger Andreas Horst Mahnken Roland B?hm Thomas Metzger Christoph Wanner Willi Jahnen-Dechent Jürgen Floege | 2003 | The Lancet2003，，9360： | 1 |
| 9 | Vitamin D reduces left atrial volume in patients with left ventricular hypertrophy and chronic kidney disease显示文摘 | Hector Tamez Carmine Zoccali David Packham Julia Wenger Ishir Bhan Evan Appelbaum Yili Pritchett Yuchiao Chang Rajiv Agarwal Christoph Wanner Donald Lloyd-Jones Jorge Cannata B. Taylor Thompson Dennis Andress Wuyan Zhang Bhupinder Singh Daniel Zehnder Aja | 2012 | American Heart Journal2012，，6： | 1 |
| 10 | Targeting cancer cells: magnetic nanoparticles as drug carriers显示文摘 | Christoph Alexiou Roswitha J. Schmid Roland Jurgons Marcus Kremer Gerhard Wanner Christian Bergemann Ernst Huenges Thomas Nawroth Wolfgang Arnold Fritz G. Parak | 2006 | European Biophysics Journal2006，，5： | 1 |
| 11 | The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial显示文摘 | Colin Baigent Martin J Landray Christina Reith Jonathan Emberson David C Wheeler Charles Tomson Christoph Wanner Vera Krane Alan Cass Jonathan Craig Bruce Neal Lixin Jiang Lai Seong Hooi Adeera Levin Lawrence Agodoa Mike Gaziano Bertram Kasiske Robert Wal | 2011 | The Lancet2011，，9784： | 1 |
| 12 | The Challenge of Sudden Death in Dialysis Patients显示文摘 | Eberhard Ritz Christoph Wanner | 2001 | Kidney International2001，60，24： | 1 |
| 13 | C-Reactive Protein: A Family of Proteins to Regulate Cardiovascular Function显示文摘 | Susanne B. Schwedler János G. Filep Jan Galle Christoph Wanner Lawrence A. Potempa | 2006 | American Journal of Kidney Diseases2006，，2： | 1 |
| 14 | Monomeric C-Reactive Protein Decreases Acetylated LDL Uptake in Human Endothelial Cells显示文摘 | Schwedler Susanne B Hansen-Hagge Thomas Reichert Matthias Schmiedeke Daniel Schneider Reinhard Galle Jan Potempa Lawrence A Wanner Christoph Filep János G | 2009 | Clinical Chemistry2009，，9： | 1 |
| 15 | Camitine abnormalities in patients with renal insufficiency显示文摘 | Christoph Wanner Walter H Hori | 1988 | Nephron1988，50，2： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员